These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24903351)

  • 1. Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.
    Akamine Y; Miura M; Komori H; Saito S; Kusuhara H; Tamai I; Ieiri I; Uno T; Yasui-Furukori N
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1087-95. PubMed ID: 24903351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The change of pharmacokinetics of fexofenadine enantiomers through the single and simultaneous grapefruit juice ingestion.
    Akamine Y; Miura M; Komori H; Tamai I; Ieiri I; Yasui-Furukori N; Uno T
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):352-7. PubMed ID: 26213156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of the SLCO2B1 c.1457C > T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans.
    Imanaga J; Kotegawa T; Imai H; Tsutsumi K; Yoshizato T; Ohyama T; Shirasaka Y; Tamai I; Tateishi T; Ohashi K
    Pharmacogenet Genomics; 2011 Feb; 21(2):84-93. PubMed ID: 21280267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the clinical pharmacokinetics of fexofenadine enantiomers.
    Akamine Y; Miura M
    Expert Opin Drug Metab Toxicol; 2018 Apr; 14(4):429-434. PubMed ID: 29635947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine.
    Dresser GK; Bailey DG; Leake BF; Schwarz UI; Dawson PA; Freeman DJ; Kim RB
    Clin Pharmacol Ther; 2002 Jan; 71(1):11-20. PubMed ID: 11823753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fexofenadine and Rosuvastatin Pharmacokinetics in Mice with Targeted Disruption of Organic Anion Transporting Polypeptide 2B1.
    Medwid S; Li MMJ; Knauer MJ; Lin K; Mansell SE; Schmerk CL; Zhu C; Griffin KE; Yousif MD; Dresser GK; Schwarz UI; Kim RB; Tirona RG
    Drug Metab Dispos; 2019 Aug; 47(8):832-842. PubMed ID: 31123035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting inhibitory effect of apple and orange juices, but not grapefruit juice, on OATP2B1-mediated drug absorption.
    Shirasaka Y; Shichiri M; Murata Y; Mori T; Nakanishi T; Tamai I
    Drug Metab Dispos; 2013 Mar; 41(3):615-21. PubMed ID: 23264447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determinants of the stereoselective pharmacokinetics of fexofenadine].
    Akamine Y
    Yakugaku Zasshi; 2015; 135(3):473-81. PubMed ID: 25759055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fruit juice inhibition of uptake transport: a new type of food-drug interaction.
    Bailey DG
    Br J Clin Pharmacol; 2010 Nov; 70(5):645-55. PubMed ID: 21039758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fruit juices on the oral bioavailability of fexofenadine in rats.
    Kamath AV; Yao M; Zhang Y; Chong S
    J Pharm Sci; 2005 Feb; 94(2):233-9. PubMed ID: 15570603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides.
    Dresser GK; Kim RB; Bailey DG
    Clin Pharmacol Ther; 2005 Mar; 77(3):170-7. PubMed ID: 15735611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified grapefruit juice eliminates two compound classes as major mediators of the grapefruit juice-fexofenadine interaction: an in vitro-in vivo "connect".
    Won CS; Lan T; Vandermolen KM; Dawson PA; Oberlies NH; Widmer WW; Scarlett YV; Paine MF
    J Clin Pharmacol; 2013 Sep; 53(9):982-90. PubMed ID: 23878024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct chiral LC-MS/MS analysis of fexofenadine enantiomers in plasma and urine with application in a maternal-fetal pharmacokinetic study.
    Pinto LSR; Vale GTD; Moreira FL; Marques MP; Coelho EB; Cavalli RC; Lanchote VL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 May; 1145():122094. PubMed ID: 32311673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells.
    Togami K; Tosaki Y; Chono S; Morimoto K; Hayasaka M; Tada H
    J Pharm Pharmacol; 2013 Jan; 65(1):22-9. PubMed ID: 23215684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of fexofenadine enantiomers in healthy subjects.
    Miura M; Uno T; Tateishi T; Suzuki T
    Chirality; 2007 Mar; 19(3):223-7. PubMed ID: 17230498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers.
    Akamine Y; Miura M; Yasui-Furukori N; Ieiri I; Uno T
    J Clin Pharm Ther; 2015 Feb; 40(1):98-103. PubMed ID: 25263393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.
    Fujita D; Saito Y; Nakanishi T; Tamai I
    Drug Metab Dispos; 2016 Jan; 44(1):1-7. PubMed ID: 26526067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate- and dose-dependent drug interactions with grapefruit juice caused by multiple binding sites on OATP2B1.
    Shirasaka Y; Mori T; Murata Y; Nakanishi T; Tamai I
    Pharm Res; 2014 Aug; 31(8):2035-43. PubMed ID: 24549825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions.
    Shirasaka Y; Shichiri M; Mori T; Nakanishi T; Tamai I
    J Pharm Sci; 2013 Sep; 102(9):3418-26. PubMed ID: 23794501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.